2NH

Naturhouse Health S.A

Consumer Defensive · EUR · F

2NH

Price

€2.512

+0.00%

Cap

€151.67M

Earnings

30d Trend

+0.9%

2NH
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

29% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level43
Quality63
Momentum83
Technical55
Fundamentals44

Raw weighted: 60×Macro 0.99 (1%)=59

RISK

43/100
90d Volatility
29.0%Moderate
ATR %
2.4%Normal
Max Drawdown (1Y)
-11.0%Resilient

QUALITY

63/100
ROE (avg)
56.9%Excellent
Piotroski F-Score
5/9Average
Debt/Equity
0.14Low leverage
Margin Stability
CV 95.1%Volatile

MOMENTUM

83/100
12-1M Momentum
+61.2%Strong uptrend
6-1M Momentum
+26.1%Positive
1M Return
-1.2%Stable
Relative Strength
+6.1% vs sectorOutperforming

TECHNICAL

55/100
RSI (14)
46.7Neutral
Price vs SMA200
+13.5%Bullish trend
MACD
-0.01Bearish momentum
Bollinger Band
30%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.070Noisy/choppy

FUNDAMENTALS

44/100
EV/EBIT
10.2Cheap
P/S
3.2Fair
PEG
9.44Overpriced growth
Shareholder Yield
0.0%Low

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months41
3-12 months72
1-5+ years58

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate Naturhouse Health S.A at 59/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 83/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

-1.2%

3 MONTHS

-0.4%

12 MONTHS

+60.1%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Momentum (83) and Quality (63) are the primary strengths. I note that fundamentals is the weakest area at 44/100 — this warrants monitoring. Historical volatility is moderate at 29%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 59/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.